nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—SLC25A6—islet of Langerhans—gestational diabetes	0.0953	0.105	CbGeAlD
Clodronate—SLC25A6—embryo—gestational diabetes	0.0921	0.102	CbGeAlD
Clodronate—SLC25A5—islet of Langerhans—gestational diabetes	0.0829	0.0914	CbGeAlD
Clodronate—SLC25A5—embryo—gestational diabetes	0.0801	0.0884	CbGeAlD
Clodronate—SLC25A6—uterus—gestational diabetes	0.0621	0.0685	CbGeAlD
Clodronate—SLC25A6—adipose tissue—gestational diabetes	0.0608	0.067	CbGeAlD
Clodronate—SLC25A5—uterus—gestational diabetes	0.054	0.0596	CbGeAlD
Clodronate—SLC25A5—adipose tissue—gestational diabetes	0.0529	0.0583	CbGeAlD
Clodronate—SLC25A4—adipose tissue—gestational diabetes	0.0495	0.0546	CbGeAlD
Clodronate—SLC25A6—head—gestational diabetes	0.0467	0.0514	CbGeAlD
Clodronate—SLC25A5—vagina—gestational diabetes	0.0439	0.0484	CbGeAlD
Clodronate—SLC25A4—vagina—gestational diabetes	0.0412	0.0454	CbGeAlD
Clodronate—SLC25A5—head—gestational diabetes	0.0406	0.0448	CbGeAlD
Clodronate—SLC25A4—head—gestational diabetes	0.038	0.0419	CbGeAlD
Clodronate—PTGS2—islet of Langerhans—gestational diabetes	0.0156	0.0172	CbGeAlD
Clodronate—PTGS2—embryo—gestational diabetes	0.0151	0.0166	CbGeAlD
Clodronate—PTGS2—Nicotinamide salvaging—NAMPT—gestational diabetes	0.0145	0.204	CbGpPWpGaD
Clodronate—PTGS2—uterus—gestational diabetes	0.0102	0.0112	CbGeAlD
Clodronate—PTGS2—adipose tissue—gestational diabetes	0.00995	0.011	CbGeAlD
Clodronate—PTGS2—vagina—gestational diabetes	0.00827	0.00912	CbGeAlD
Clodronate—PTGS2—Nicotinate metabolism—NAMPT—gestational diabetes	0.0077	0.108	CbGpPWpGaD
Clodronate—PTGS2—head—gestational diabetes	0.00764	0.00843	CbGeAlD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.00464	0.0653	CbGpPWpGaD
Clodronate—Digestion impaired—Glyburide—gestational diabetes	0.00402	0.182	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—AR—gestational diabetes	0.0033	0.0464	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GGCT—gestational diabetes	0.00235	0.0332	CbGpPWpGaD
Clodronate—Hepatic function abnormal—Glyburide—gestational diabetes	0.00223	0.101	CcSEcCtD
Clodronate—Renal failure acute—Glyburide—gestational diabetes	0.00211	0.0956	CcSEcCtD
Clodronate—SLC25A5—Metabolism—GLS2—gestational diabetes	0.00206	0.029	CbGpPWpGaD
Clodronate—Renal impairment—Glyburide—gestational diabetes	0.00205	0.0928	CcSEcCtD
Clodronate—SLC25A6—Metabolism—GGCT—gestational diabetes	0.00197	0.0278	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GLS2—gestational diabetes	0.00172	0.0243	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GGCT—gestational diabetes	0.00154	0.0217	CbGpPWpGaD
Clodronate—SLC25A5—Disease—RBP4—gestational diabetes	0.0015	0.0211	CbGpPWpGaD
Clodronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—gestational diabetes	0.00147	0.0207	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NAMPT—gestational diabetes	0.00135	0.019	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GLS2—gestational diabetes	0.00135	0.019	CbGpPWpGaD
Clodronate—SLC25A5—Disease—GCK—gestational diabetes	0.00134	0.0188	CbGpPWpGaD
Clodronate—SLC25A6—Disease—RBP4—gestational diabetes	0.00126	0.0177	CbGpPWpGaD
Clodronate—PTGS2—Overview of nanoparticle effects—TNF—gestational diabetes	0.00117	0.0165	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NAMPT—gestational diabetes	0.00113	0.0159	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—NAMPT—gestational diabetes	0.00113	0.0159	CbGpPWpGaD
Clodronate—SLC25A6—Disease—GCK—gestational diabetes	0.00112	0.0158	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GCK—gestational diabetes	0.00112	0.0158	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.0011	0.0154	CbGpPWpGaD
Clodronate—Anaemia—Glyburide—gestational diabetes	0.00109	0.0491	CcSEcCtD
Clodronate—Angioedema—Glyburide—gestational diabetes	0.00107	0.0486	CcSEcCtD
Clodronate—SLC25A4—Disease—RBP4—gestational diabetes	0.000982	0.0138	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—NAMPT—gestational diabetes	0.000945	0.0133	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GCK—gestational diabetes	0.000939	0.0132	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—LEP—gestational diabetes	0.000932	0.0131	CbGpPWpGaD
Clodronate—Anorexia—Glyburide—gestational diabetes	0.000914	0.0414	CcSEcCtD
Clodronate—SLC25A4—Disease—NAMPT—gestational diabetes	0.000881	0.0124	CbGpPWpGaD
Clodronate—SLC25A4—Disease—GCK—gestational diabetes	0.000875	0.0123	CbGpPWpGaD
Clodronate—Dyspnoea—Glyburide—gestational diabetes	0.000855	0.0387	CcSEcCtD
Clodronate—Dyspepsia—Glyburide—gestational diabetes	0.000844	0.0382	CcSEcCtD
Clodronate—Decreased appetite—Glyburide—gestational diabetes	0.000833	0.0377	CcSEcCtD
Clodronate—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000828	0.0375	CcSEcCtD
Clodronate—SLC25A5—Metabolism—CYP19A1—gestational diabetes	0.000819	0.0115	CbGpPWpGaD
Clodronate—Urticaria—Glyburide—gestational diabetes	0.000762	0.0345	CcSEcCtD
Clodronate—Abdominal pain—Glyburide—gestational diabetes	0.000758	0.0343	CcSEcCtD
Clodronate—SLC25A4—Metabolism—NAMPT—gestational diabetes	0.000738	0.0104	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GCK—gestational diabetes	0.000733	0.0103	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—LEP—gestational diabetes	0.000728	0.0102	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CYP19A1—gestational diabetes	0.000687	0.00967	CbGpPWpGaD
Clodronate—Pruritus—Glyburide—gestational diabetes	0.000678	0.0307	CcSEcCtD
Clodronate—Diarrhoea—Glyburide—gestational diabetes	0.000656	0.0297	CcSEcCtD
Clodronate—Vomiting—Glyburide—gestational diabetes	0.00061	0.0276	CcSEcCtD
Clodronate—Rash—Glyburide—gestational diabetes	0.000604	0.0274	CcSEcCtD
Clodronate—Dermatitis—Glyburide—gestational diabetes	0.000604	0.0273	CcSEcCtD
Clodronate—PTGS2—Spinal Cord Injury—LEP—gestational diabetes	0.000586	0.00825	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000576	0.00811	CbGpPWpGaD
Clodronate—Nausea—Glyburide—gestational diabetes	0.000569	0.0258	CcSEcCtD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000554	0.0078	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—gestational diabetes	0.000539	0.00759	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CYP19A1—gestational diabetes	0.000536	0.00755	CbGpPWpGaD
Clodronate—SLC25A5—Disease—FGF2—gestational diabetes	0.00052	0.00732	CbGpPWpGaD
Clodronate—SLC25A6—Disease—FGF2—gestational diabetes	0.000436	0.00613	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—TNF—gestational diabetes	0.000343	0.00483	CbGpPWpGaD
Clodronate—SLC25A4—Disease—FGF2—gestational diabetes	0.00034	0.00479	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GGCT—gestational diabetes	0.000305	0.00429	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000303	0.00426	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—gestational diabetes	0.000271	0.00382	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GLS2—gestational diabetes	0.000266	0.00375	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000238	0.00335	CbGpPWpGaD
Clodronate—PTGS2—Disease—RBP4—gestational diabetes	0.000194	0.00273	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000184	0.0026	CbGpPWpGaD
Clodronate—PTGS2—Disease—NAMPT—gestational diabetes	0.000174	0.00245	CbGpPWpGaD
Clodronate—PTGS2—Disease—GCK—gestational diabetes	0.000173	0.00244	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NAMPT—gestational diabetes	0.000146	0.00205	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GCK—gestational diabetes	0.000145	0.00204	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP19A1—gestational diabetes	0.000106	0.00149	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGF2—gestational diabetes	6.73e-05	0.000947	CbGpPWpGaD
